Dr. Miyamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-5866Fax+1 617-726-3603
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
- Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
- Harvard Medical SchoolClass of 2006
Certifications & Licensure
- MA State Medical License 2008 - 2026
- ME State Medical License 2020 - 2021
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTO...Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song
European Urology Oncology. 2024-10-01 - Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized P...Amy J Wisdom, Beow Y Yeap, Jeff M Michalski, Nora K Horick, Anthony L Zietman
International Journal of Radiation Oncology, Biology, Physics. 2024-09-30 - Imposter among us: field cancerization in the bladder.Daniel J Rodden, Ella H Chung, Rea Pittie, David T Miyamoto
Translational Andrology and Urology. 2024-07-31
Journal Articles
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerDavid T Miyamoto, Aditya Bardia, Lecia V Sequist, Laura M Spring, Daniel A Haber, Mark Kalinich, Clinical Cancer Research
Press Mentions
- MRI-Guided SBRT Shows Sustained Benefits for Prostate CancerOctober 4th, 2024
- New Discovery by Massachusetts General Hospital May Help Medical Laboratories Preserve Blood for DNA Analysis, Thus Allowing Isolation of CTCs up to 72 Hours After CollectionJune 27th, 2018
- Henning Willers, MD and David Miyamoto, MD, PhD Receive $150,000 Grant from Aid for Cancer ResearchMay 21st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: